Navigation Links
AEterna Zentaris Receives US$5.5 Million from Institutional Investors
Date:10/24/2009

rd, Quebec City, Canada G1P 4P5. This announcement is neither an offer to sell nor a solicitation of an offer to buy any of AEterna Zentaris' common shares or warrants. No offer, solicitation or sale will be made in any jurisdiction in which such offer, solicitation or sale is unlawful.

Rodman & Renshaw, LLC, a subsidiary of Rodman & Renshaw Capital Group, Inc., (Nasdaq: RODM), acted as the exclusive placement agent for the transaction.

About AEterna Zentaris Inc.

AEterna Zentaris Inc. is a global biopharmaceutical company focused on endocrine therapy and oncology, with proven expertise in drug discovery, development and commercialization. News releases and additional information are available at www.aezsinc.com.

Forward-Looking Statements

This press release contains forward-looking statements made pursuant to the safe harbor provisions of the U.S. Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties, which could cause the Company's actual results to differ materially from those in the forward-looking statements. Such risks and uncertainties include, among others, the availability of funds and resources to pursue R&D projects, the successful and timely completion of clinical studies, the ability of the Company to take advantage of business opportunities in the pharmaceutical industry, uncertainties related to the regulatory process and general changes in economic conditions. Investors should consult the Company's quarterly and annual filings with the Canadian and U.S. securities commissions for additional information on risks and uncertainties relating to the forward-looking statements. Investors are cautioned not to rely on these forward-looking statements. The Company does not undertake to update these forward-looking statements. We disclaim any obligation to update any such factors or to pub
'/>"/>

SOURCE AETERNA ZENTARIS INC.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. AEterna Zentaris completes management team with the appointment of Chief Medical Officer
2. AEterna Zentaris to Present at Upcoming UBS Global Life Sciences Conference in New York
3. AEterna Zentaris Announces Outcome of Managements Strategic Review
4. AEterna Zentaris to Further Develop Three Follow-up Multi-targeted Cytotoxic Candidates to AEZS-112 as Potential Novel Cancer Treatment
5. AEterna Zentaris Reports First Patients Treated with Anti-Cancer Compound AEZS-108 in Phase 2 Trial in Ovarian and Endometrial Cancers
6. AEterna Zentaris to Present at the Upcoming Roth Capital Partners 20th Annual OC Growth Stock Conference in Dana Point, California
7. Aeterna Zentaris to Announce Fourth Quarter and Full-Year 2007 Financial and Operating Results on March 5, 2008
8. AEterna Zentaris Announces the Departure of SVP, Administrative and Legal Affairs
9. AEterna Zentaris and Paladin Labs Announce Sale and Purchase of Miltefosine Rights
10. Aeterna Zentaris Reports Fourth Quarter and Full-Year 2007 Financial and Operating Results
11. Aeterna Zentaris Begins Second Phase 3 Trial of Cetrorelix for Benign Prostatic Hyperplasia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... 15 Aethlon Medical, Inc. (OTC Bulletin ... Schorey and Dr. Wayne Comper have ... Inc. (ESI). Both Dr. Schorey and Dr. Comper ... a wholly owned subsidiary of Aethlon Medical, was ... Hemopurifier®, a medical device being advanced as an ...
(Date:12/15/2009)... BRIARCLIFF MANOR, N.Y., Dec. 15 The ... announced that the professional society is continuing to ... is being held in Arlington, VA, April 19-21, ... society is encouraging non-members to join the organization ... event. The submission deadline is 12 AM EST, ...
(Date:12/15/2009)... , - ... the Ability of,Cardiopoietic Cells to Restore Cardiac Function ... leading Belgian biotechnology company specialising,in cell-based therapies for ... has completed, two months ahead of schedule,enrolment in ... trial of C-Cure, a,unique stem cell therapy for ...
(Date:12/14/2009)... Dyadic International, Inc. (Pink Sheets: DYAI) ("Dyadic") announced ... The Scripps Research Institute ("Scripps") by entering into ... of Dyadic,s patented and proprietary C1 fungus ("C1"). ... successful relationship between the two organizations which began ... annotate the C1 genome for the first time. ...
Breaking Biology Technology:Aethlon Medical Appoints Jeff Schorey and Wayne Comper to Exosome Sciences Advisory Board 2Aethlon Medical Appoints Jeff Schorey and Wayne Comper to Exosome Sciences Advisory Board 3Aethlon Medical Appoints Jeff Schorey and Wayne Comper to Exosome Sciences Advisory Board 4Aethlon Medical Appoints Jeff Schorey and Wayne Comper to Exosome Sciences Advisory Board 5The International Society for Medical Publication Professionals Announces Call for Abstracts for Its 6th Annual Meeting 2The International Society for Medical Publication Professionals Announces Call for Abstracts for Its 6th Annual Meeting 3Cardio3 BioSciences Completes Patient Enrolment in First Stage of Pivotal Trial of C-Cure(R) in Heart Failure 2Cardio3 BioSciences Completes Patient Enrolment in First Stage of Pivotal Trial of C-Cure(R) in Heart Failure 3Dyadic International Extends Collaboration With The Scripps Research Institute 2Dyadic International Extends Collaboration With The Scripps Research Institute 3Dyadic International Extends Collaboration With The Scripps Research Institute 4Dyadic International Extends Collaboration With The Scripps Research Institute 5
... and Reliable DNA Extraction That Generates DNA Templates ... Tails Using prepGEM(TM) Yielded Over 34 Times the ... Extraction Kits -- SOLANA BEACH, Calif. and HAMILTON, ... a provider of innovative enzyme-based products for DNA ...
... Medical, Inc. (Nasdaq: ATSI ), manufacturer and ... announced participation in the upcoming 89th Annual Meeting of ... in Boston from May 10-13, 2009. The Annual ... and allied health professionals from around the world that ...
... Ltd. (SIX:,ARPN) will today discuss potential strategic scenarios with ... at 10am CET in Reinach,Switzerland. , ... Arpida has,initiated a thorough analysis with the aim to ... international experts in this field. , ...
Other Biology Technology:ZyGEM Releases Application Note Showing its DNA Extraction Kits Rapidly Produce High Yields of Quality DNA 2ZyGEM Releases Application Note Showing its DNA Extraction Kits Rapidly Produce High Yields of Quality DNA 3ZyGEM Releases Application Note Showing its DNA Extraction Kits Rapidly Produce High Yields of Quality DNA 4ATS Medical Announces Participation in the Annual Meeting of the American Association for Thoracic Surgeons 2ATS Medical Announces Participation in the Annual Meeting of the American Association for Thoracic Surgeons 3ATS Medical Announces Participation in the Annual Meeting of the American Association for Thoracic Surgeons 4Arpida to Discuss Strategy With Shareholders 2
(Date:12/14/2009)... A team of researchers from the Astrobiology Centre (INTA-CSIC) ... considered essential to the formation of the most basic ... blue. In order to carry out this study, published ... scientists recreated the chemical conditions of the early Earth. ... dissolved in ammoniac solutions it produces hydrogen cyanide, a ...
(Date:12/13/2009)... help to engineer plants that take advantage of elevated ... could help to engineer crops that take advantage of ... dioxide they need for photosynthesis through microscopic breathing pores ... of the gas gained, they lose hundreds of water ... to save water when CO 2 is abundant, ...
(Date:12/11/2009)... with the global "green" trend, educators worldwide ... to enhance students, science knowledge. Studies have ... curriculum raises not just science scoresenvironmental-based lessons ... other subject areas. Naturally, educators are interested ... relevant lessons into the classroom in hopes ...
Breaking Biology News(10 mins):Prussian blue linked to the origin of life 2Newly identified enzymes help plants sense elevated CO2 and could lead to water-wise crops 2Newly identified enzymes help plants sense elevated CO2 and could lead to water-wise crops 3Students learn environmental stewardship, improve science scores 2ChildCare Education Institute Gives Child Care Staff a Professional Development Course in Observance of National Infant Mortality Awareness Month 56027 1ChildCare Education Institute Gives Child Care Staff a Professional Development Course in Observance of National Infant Mortality Awareness Month 56027 2A Mediterranean Approach to Flavorful Living 56023 1A Mediterranean Approach to Flavorful Living 56023 2A Mediterranean Approach to Flavorful Living 56023 3Resident Duty Hour Reform Associated With Increased Complication Rate 56018 1Resident Duty Hour Reform Associated With Increased Complication Rate 56018 2Resident Duty Hour Reform Associated With Increased Complication Rate 56018 3
... the Vaccine and Gene Therapy Institute (VGTI) at Oregon ... to better detect future monkeypox or smallpox outbreaks. The ... outbreak in the Midwest -- monkeypox is closely related ... outbreak was larger than the 72 cases reported by ...
... Scientists have used a glowing protein from fireflies to ... important target for new drugs to treat cancer, autoimmune ... known as IKK (for IKappa kinase), regulates processes that ... linked these changes to many different disorders. , "Our ...
... team of researchers has obtained data that help clarify our ... cats that once roamed the prehistoric New World. , The ... Biology by Ross Barnett of the University of Oxford and ... and Australia. , Toward the end of the last Ice ...
Other Biology News:Researchers develop new testing methods for potential monkeypox or smallpox outbreak 2Researchers develop new testing methods for potential monkeypox or smallpox outbreak 3Firefly protein lets researchers monitor molecule linked to cancer 2Firefly protein lets researchers monitor molecule linked to cancer 3DNA traces evolution of extinct sabertooths and the American cheetah-like cat 2
Mouse monoclonal [3B6] to HSV1 + HSV2 ICP5 Major Capsid Protein ( Abpromise for all tested applications)....
Phosphotyrosine IgG mouse monoclonal antibody: Alkaline Phosphatase conjugate...
Rabbit polyclonal to GPCR G2A ( Abpromise for all tested applications). entrezGeneID: 29933 SwissProtID: Q9UNW8...
... reagent has been developed for use ... reduction of nonspecific background staining due ... describe blocking peroxidase with hydrogen peroxide. ... in combination with additional novel components ...
Biology Products: